Hipro Glycosylated Hemoglobin (HbA1c) Test System
Sep 2024
892d
Shijiazhuang Hipro Biotechnology Co., Ltd. has submitted 1 FDA 510(k) premarket notifications since 2024, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Hemoglobin A1c Test System . Use the specialty filter in the sidebar to narrow results.